Sign Up Free!: I want to create and share social media releases.
Sign Up/Sign In

M. D. Anderson's Lois Ramondetta Recognized for Excellence in Patient Care

10.23.2009 – ...

Synovate appoints Head of Oncology: 10.19.2009 - US – The healthcare division of leading global market intelligence company Synovate has appointed Jackie Ilacqua to the newly created role of Head of Oncology. Formerly responsible for building and...; Read More

Synovate Healthcare launches global Oncology capabilities in eight new markets: 10.16.2009 - NEW YORK — Leading market intelligence company Synovate today announced the expansion of its Global Oncology Monitor in to eight new markets. Previously covering thirteen markets - the US, the...; Read More

MUGARD DATA FROM UK STUDY SHOWS PREVENTION OF ORAL MUCOSITIS IN HEAD AND NECK CANCER PATIENTS: 07.23.2009 - DALLAS, TX, July 23, 2009, ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), announced today that its European partner, SpePharm, is collecting data from a post approval study of MuGard in head and...; Read More

ACCESS PHARMACEUTICALS ANNOUNCES COMMERCIAL LAUNCH OF MUGARD™ IN GREECE BY SPEPHARM: 06.29.2009 - DALLAS, TX, June 29, 2009, ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), announced today that its European partner, SpePharm has commenced commercial launch of MuGard in Greece. This follows previous commercial launches...; Read More

ACCESS PHARMACEUTICALS ANNOUNCES GRANTING OF TWO US PATENTS FOR MUGARD™: 06.10.2009 - DALLAS, TX, June 10, 2009, ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), announced today that the Company has received issue notifications from the United States Patent and Trademark Office that two US...; Read More

Access Pharmaceuticals Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan: 06.01.2009 - DALLAS, June 1 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (http://www.accesspharma.com) (OTC Bulletin Board: ACCP - News), provided an update today on the progress in the Company's clinical development plan for ProLindac,...; Read More

ACCESS PHARMACEUTICALS PROVIDES UPDATE ON GLOBAL LAUNCH OF MUGARD™: 05.27.2009 - DALLAS, TX, May 27 2009, ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), (http://www.accesspharma.com) announced today that MuGard™, its proprietary oral mucositis product has been launched in Germany, Italy, UK, Greece and the...; Read More